Therapeutic Compounds

Abstract: The present disclosure relates to compounds that are IL-17A modulators. The compounds have the structural Formula I defined herein. The present disclosure also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with modulation of IL-17A activity.

Patent Information

Application #

Filing Date

29 May 2025

Publication Number

36/2025

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

SANOFI

46 avenue de la Grande Armée 75017 Paris

Inventors

1. BUNING, Christian

c/o Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt am Main

2. HALLAND, Nis

c/o Sanofi- Aventis Deutschland GmbH Patent Department 65926 Frankfurt am Main

3. HEINELT, Uwe

c/o Sanofi- Aventis Deutschland GmbH Patent Department 65926 Frankfurt am Main

4. MATTER, Hans

c/o Sanofi- Aventis Deutschland GmbH Patent Department 65926 Frankfurt am Main

5. LINNEY, Ian, Duncan

c/o C4X Discovery Limited Broadhurst House 56 Oxford Street Manchester M1 6EU

6. WESTERMANN, Jan-Christoph

c/o C4X Discovery Limited Broadhurst House 56 Oxford Street Manchester M1 6EU

Specification

Documents

Application Documents

#	Name	Date
1	202517051953-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [29-05-2025(online)].pdf	2025-05-29
2	202517051953-STATEMENT OF UNDERTAKING (FORM 3) [29-05-2025(online)].pdf	2025-05-29
3	202517051953-REQUEST FOR EXAMINATION (FORM-18) [29-05-2025(online)].pdf	2025-05-29
4	202517051953-FORM 18 [29-05-2025(online)].pdf	2025-05-29
5	202517051953-FORM 1 [29-05-2025(online)].pdf	2025-05-29
6	202517051953-DECLARATION OF INVENTORSHIP (FORM 5) [29-05-2025(online)].pdf	2025-05-29
7	202517051953-COMPLETE SPECIFICATION [29-05-2025(online)].pdf	2025-05-29
8	202517051953-FORM-26 [13-08-2025(online)].pdf	2025-08-13
9	202517051953-Proof of Right [09-09-2025(online)].pdf	2025-09-09
10	202517051953-FORM 3 [23-10-2025(online)].pdf	2025-10-23